{"gene":"ELOVL4","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2001,"finding":"ELOVL4 encodes a retinal photoreceptor-specific protein with homology to yeast proteins involved in very long-chain fatty acid biosynthesis; a 5-bp deletion causing C-terminal truncation segregates with autosomal dominant Stargardt-like macular dystrophy (STGD3) and adMD.","method":"Genetic mapping, recombination breakpoint analysis, direct sequencing, bioinformatic homology analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — foundational discovery paper with genetic mapping and sequencing; strongly replicated across multiple subsequent studies","pmids":["11138005"],"is_preprint":false},{"year":2004,"finding":"Wild-type ELOVL4 localizes predominantly to the endoplasmic reticulum (ER) via a C-terminal dilysine (KXKXX) ER-retention/retrieval motif; disease-associated mutations that truncate the C-terminus cause mislocalization to the Golgi in COS-7 and CHO cells, and similarly to the ER in human photoreceptors.","method":"Immunofluorescence with organelle markers, immunoelectron microscopy in transfected cells and human photoreceptors","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 — direct localization with multiple organelle markers, replicated by multiple independent labs","pmids":["15028284"],"is_preprint":false},{"year":2004,"finding":"Wild-type ELOVL4 fused to EGFP localizes to the ER; the C-terminally truncated mutant mislocalizes to cytoplasmic aggregates and induces apoptotic cell death in transfected cells.","method":"Confocal fluorescence microscopy with ER/mitochondria/peroxisome/Golgi markers, TUNEL staining in NIH 3T3 and HEK293 cells","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 2 — multiple organelle markers used; single lab, consistent with other localization studies","pmids":["15073583"],"is_preprint":false},{"year":2004,"finding":"A novel Y270X stop mutation in ELOVL4 causes mislocalization of the mutant protein away from the ER in transfected NIH-3T3 and HEK293 cells, consistent with loss of the C-terminal ER-retention signal.","method":"EGFP fusion protein transfection, confocal microscopy co-localized with ER marker (pDsRed2-ER)","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment; single lab but consistent with multiple other studies","pmids":["15557430"],"is_preprint":false},{"year":2005,"finding":"Disease-associated C-terminal truncation mutants of ELOVL4 accumulate in aggresome-like juxtanuclear inclusions; when co-expressed, mutant ELOVL4 physically interacts with and sequesters wild-type ELOVL4 into these aggresomes, demonstrating a dominant-negative mechanism.","method":"Co-immunoprecipitation, immunofluorescence in COS-7 and HEK293T cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP and localization; independently replicated by multiple groups","pmids":["16036915"],"is_preprint":false},{"year":2005,"finding":"ELOVL4 mutant protein (5-bp deletion) interacts with wild-type ELOVL4 to form higher molecular mass complexes that accumulate in perinuclear aggresomes, as shown by 2D gel electrophoresis and FRET analysis; mutant protein expression also induces unfolded protein response (BiP and CHOP upregulation).","method":"Immunocytochemistry, 2D gel electrophoresis, FRET, western blotting in COS-7 cells","journal":"Molecular vision","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (FRET, 2D-gel, ICC); corroborates dominant-negative mechanism","pmids":["16163264"],"is_preprint":false},{"year":2005,"finding":"ELOVL4 mutants lose ER retention and sequester wild-type ELOVL4 into cytoplasmic aggregates; deletion of the ER retention signal (KAKGD→5A) from wild-type ELOVL4 recapitulates mislocalization; mutant expression induces UPR markers BiP and CHOP.","method":"Fluorescence microscopy, co-immunoprecipitation, sucrose gradient fractionation, western blot in HEK293 and COS cells","journal":"Molecular vision","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods; demonstrates ER-retention signal requirement functionally","pmids":["16145543"],"is_preprint":false},{"year":2007,"finding":"Homozygous loss of ELOVL4 (knock-in 5-bp deletion or full knockout) in mice causes global depletion of very long-chain fatty acids (≥C28) in the epidermis, loss of omega-O-acylceramides, defective lamellar body secretion, disrupted stratum corneum lamellar membranes, and consequent neonatal lethality due to failed epidermal permeability barrier.","method":"Knock-in/knockout mouse model, lipid analysis (ceramide/glucosylceramide fractions), electron microscopy of skin ultrastructure, permeability barrier assay","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 — mouse KO/KI with biochemical lipid analysis and ultrastructural phenotype; replicated by at least two independent labs","pmids":["17208947"],"is_preprint":false},{"year":2007,"finding":"ELOVL4 knockout (Elovl4-/-) mice lack ceramides with omega-hydroxy very long-chain fatty acids (≥C28), accumulate C26-containing ceramides (implicating C26 as an ELOVL4 substrate), and die postnatally from defective skin water permeability barrier, confirming ELOVL4 is required for C28+ fatty acid synthesis essential for skin barrier.","method":"Gene knockout mouse model, lipid analysis, skin histology, electron microscopy, transepidermal water loss measurement","journal":"International journal of biological sciences","confidence":"High","confidence_rationale":"Tier 1-2 — KO mouse with biochemical and ultrastructural data; independently confirms findings in PMID 17208947","pmids":["17311087"],"is_preprint":false},{"year":2007,"finding":"Elovl4 Y270X and complete knockout mice die perinatally from dehydration due to defective epidermal permeability barrier; biochemical analysis reveals a significant reduction in free fatty acids longer than C26 in homozygous mutant skin, establishing ELOVL4 as an elongase of C26+ fatty acids.","method":"Knock-in/knockout mouse models, fatty acid profiling of skin, transepidermal water loss measurement","journal":"International journal of biological sciences","confidence":"High","confidence_rationale":"Tier 2 — KO/KI mouse with biochemical lipid analysis; independent replication of epidermal phenotype","pmids":["17304340"],"is_preprint":false},{"year":2007,"finding":"Stgd3 knock-in mouse retinas show selective deficiency of C32-C36 acyl phosphatidylcholines but no cellular stress response, indicating that lipid product deficiency (rather than ER stress) is the primary pathogenic mechanism in STGD3 retina.","method":"Mass spectrometry (lipid profiling) of retina from Stgd3 knock-in mice, ER stress marker analysis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — knock-in mouse with lipidomics; single lab","pmids":["17983602"],"is_preprint":false},{"year":2008,"finding":"ELOVL4 is a fatty acid condensing enzyme directly responsible for synthesis of C28-C30 saturated VLC-FA and C28-C38 VLC-PUFA; gain-of-function adenoviral expression of mouse Elovl4 in cardiomyocytes and ARPE-19 cells supplemented with 24:0, 20:5n3, or 22:5n3 produced elongated products up to C30 (saturated) or C38 (PUFA).","method":"Gain-of-function adenoviral transduction of Elovl4 in cell lines, fatty acid supplementation, GC-MS lipid analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic gain-of-function assay in cells with substrate supplementation; foundational paper establishing elongase activity","pmids":["18728184"],"is_preprint":false},{"year":2010,"finding":"ELOVL4 protein is not involved in DHA (22:6n3) biosynthesis from short-chain precursors (18:3n3 and 22:5n3), as shown by siRNA knockdown in cone photoreceptor-derived 661w cells.","method":"siRNA knockdown of ELOVL4 in 661w cells with fatty acid precursor labeling","journal":"Advances in experimental medicine and biology","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function in relevant cell type with specific substrate testing; single lab","pmids":["20238022"],"is_preprint":false},{"year":2011,"finding":"Photoreceptor-specific conditional knockout of Elovl4 in mice causes significant depletion of retinal glycerophospholipids containing VLC-PUFAs (particularly in the sn-1 position of phosphatidylcholine), abnormal lipid droplet and lipofuscin-like granule accumulation, and photoreceptor-specific defects in visual response by ERG.","method":"Cre-lox photoreceptor-specific KO mouse, HPLC-MS lipidomics, immunofluorescence, histology, electroretinography","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — conditional KO with lipidomics and functional ERG readout; establishes essential role of ELOVL4 in retinal VLC-PUFA synthesis and function","pmids":["22199362"],"is_preprint":false},{"year":2011,"finding":"ELOVL4 preferentially elongates 20:5n3 (EPA) over 20:4n6 or 22:6n3 to produce C28-C38 VLC-PUFA; C34 and C36 VLC-PUFAs are the predominant products; only ELOVL4-expressing cells (not controls) synthesize VLC-PUFA ≥C28 from these precursors.","method":"Adenoviral ELOVL4 expression in PC12 cells, fatty acid supplementation, GC-MS lipid analysis","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 — cell-based enzymatic assay with multiple substrates tested; defines substrate preference","pmids":["22158834"],"is_preprint":false},{"year":2011,"finding":"Epidermal-targeted transgenic expression of wild-type Elovl4 (involucrin promoter) rescues neonatal lethality of homozygous Stgd3 mice, restoring epidermal C28-C36 acylceramides and (O-linoleoyl)-omega-hydroxy C28-C36 fatty acids and skin barrier function, establishing that epidermal ELOVL4-mediated VLC-FA synthesis is essential for survival.","method":"Transgenic rescue experiment, lipid analysis, skin barrier function assay","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1-2 — transgenic rescue with biochemical validation; definitively establishes tissue-specific function","pmids":["21429867"],"is_preprint":false},{"year":2013,"finding":"The STGD3-associated C-terminally truncated ELOVL4 mutant lacks intrinsic condensation (elongase) activity in both cell-based and cell-free microsome assays, and co-expression with wild-type ELOVL4 causes dominant-negative suppression of wild-type ELOVL4 localization and enzymatic activity, reducing VLC-PUFA synthesis.","method":"Cell-based and cell-free microsome condensation assays, co-expression experiments, VLC-PUFA quantification by GC-MS","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assay with mutagenesis/truncation variants + cell-free microsome assay; directly demonstrates catalytic loss and dominant-negative enzymatic effect","pmids":["23509295"],"is_preprint":false},{"year":2013,"finding":"Rod-specific and cone-specific conditional Elovl4 knockout mice show near-total loss of retinal C30-C34 VLC-PUFAs without electrophysiological or behavioral deficits, whereas transgenic mice expressing the human STGD3 mutant ELOVL4 allele develop typical rod-cone dystrophy despite similar VLC-PUFA depletion, suggesting mutant protein toxicity (not VLC-PUFA loss alone) drives the STGD3 phenotype.","method":"Conditional KO and transgenic mouse models, GC-MS (VLC-PUFA and A2E measurement), ERG, electron microscopy, optomotor tracking","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — multiple genetically distinct mouse models with multiple functional readouts; resolves mechanism debate","pmids":["23479632"],"is_preprint":false},{"year":2014,"finding":"ELOVL4 elongase activity requires: (1) its localization to the ER microenvironment (displacement from ER abolishes condensation activity); (2) specific active-site histidine residues (His mutants lose elongase activity); N-glycosylation is dispensable for enzyme function.","method":"Overexpression of full-length, N-glycosylation-deficient, ER-retention mutant, and active-site histidine mutants of ELOVL4 with VLC-FA elongation assay by GC-MS","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 — active-site mutagenesis combined with in-cell enzymatic assay; identifies catalytic residues and ER requirement","pmids":["24569140"],"is_preprint":false},{"year":2014,"finding":"In transgenic Xenopus laevis rod photoreceptors, wild-type ELOVL4 localizes primarily to inner segments; the disease-linked C-terminal truncation mutant (lacking the dilysine ER-retention motif) mislocalizes to post-Golgi compartments and outer segment disks; co-expression of mutant and WT ELOVL4 does not cause mislocalization or aggregation of WT protein in rods in vivo.","method":"Transgenic Xenopus laevis rod photoreceptor expression, immunofluorescence and direct fluorescence microscopy","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 — in vivo localization in native photoreceptors with functional relevance to disease mechanism","pmids":["24833735"],"is_preprint":false},{"year":2014,"finding":"ELOVL4 is expressed in meibomian gland and sebaceous gland holocrine cells, localizing to structures surrounding lipid deposits; Stgd3 mutant mice show meibomian gland abnormalities including protruding orifices and altered gland anatomy resembling evaporative dry eye, implicating ELOVL4-derived VLC-FAs in meibum composition.","method":"Immunohistochemistry in eyelid tissue, histology (H&E), phenotypic assessment in Stgd3 mice","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct localization in tissue with functional phenotypic consequence in mutant mice; single lab","pmids":["24677106"],"is_preprint":false},{"year":2010,"finding":"The ELOVL4ΔC (truncation) mutant forms homo-oligomers more strongly than wild-type ELOVL4 and also interacts via hetero-oligomerization with other elongases (ELOVL1-7) and with other VLCFA elongation machinery components, suggesting that ELOVL4ΔC disrupts the entire VLCFA elongation pathway through broad hetero-oligomeric interactions.","method":"Co-immunoprecipitation of ELOVL4ΔC with elongases ELOVL1-7 and other elongation complex components in HEK293T cells","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP with multiple partners; single lab; expands mechanistic understanding of dominant-negative effect","pmids":["21139992"],"is_preprint":false},{"year":2017,"finding":"ELOVL4 expression in the brain is restricted primarily to neurons (not astrocytes or radial glia), with expression beginning by embryonic day 18 and persisting in adult cerebral cortex, hippocampus, cerebellum, thalamus, hypothalamus, midbrain, pons, and medulla; some oligodendrocytes in white matter also express ELOVL4; subcellular localization is restricted to cell bodies consistent with ER residence.","method":"Immunolabeling with cell-type-specific markers (NeuN, GFAP, Olig2, etc.) in mouse brain sections from E18 to P60","journal":"Frontiers in neuroanatomy","confidence":"Medium","confidence_rationale":"Tier 2-3 — systematic immunolabeling across developmental stages; single lab","pmids":["28507511"],"is_preprint":false},{"year":2017,"finding":"Homozygous expression of the STGD3 Elovl4 mutation (with skin-specific WT rescue) causes seizures by P19 and death by P21 in mice; hippocampal slices show aberrant epileptogenic activity; cultured hippocampal neurons exhibit accelerated synaptic vesicle release kinetics (FM1-43 assay); supplementation with VLC-SFA rescues defective synaptic release to WT rates, establishing that ELOVL4's VLC-SFA products regulate synaptic release kinetics.","method":"Double transgenic mouse model with skin rescue, hippocampal slice electrophysiology, FM1-43 dye release assay, VLC-SFA supplementation rescue experiment","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including functional rescue with VLC-SFA; directly links ELOVL4 products to synaptic release kinetics","pmids":["29168048"],"is_preprint":false},{"year":2018,"finding":"ELOVL4-derived VLC ceramides (≥C26) stabilize tight junctions in retinal vascular endothelium; ELOVL4 overexpression decreases basal permeability and inhibits VEGF- and IL-1β-induced permeability; ω-linked acyl-VLC ceramides co-localize with tight junction complexes by ultrastructural analysis; intravitreal AAV2-hELOVL4 delivery reduces diabetes-induced retinal vascular permeability.","method":"ELOVL4 overexpression in endothelial cells, permeability assays, ultrastructure (EM) and lipidomics, intravitreal AAV delivery in diabetic mice, immunostaining of TJ proteins","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including in vivo AAV rescue and ultrastructural colocalization; establishes VLC ceramide-tight junction mechanistic link","pmids":["29362226"],"is_preprint":false},{"year":2018,"finding":"ELOVL4 protein is expressed in spermatocytes during rat spermatogenesis; spermatocytes (with highest ELOVL4 protein levels) are the only testicular cells that produce C26-C32 VLC-PUFAs, directly correlating ELOVL4 enzymatic activity with VLC-PUFA synthesis in germ cells.","method":"Western blot, immunohistochemistry, [³H]arachidonate elongation assay in isolated spermatocytes, round spermatids, Sertoli cells; postnatal developmental expression analysis","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — enzymatic activity assay in primary cells correlated with protein levels; single lab","pmids":["29724783"],"is_preprint":false},{"year":2020,"finding":"The SCA34-causing W246G mutant ELOVL4 protein is mislocalized (punctate and aggregated rather than ER-distributed) in patient-derived skin fibroblasts, supporting a dominant-negative effect on protein localization as a pathogenic mechanism.","method":"Immunohistochemistry of dermal fibroblasts from patient skin biopsy","journal":"Neurology. Genetics","confidence":"Medium","confidence_rationale":"Tier 3 — single imaging method in patient-derived cells; supports but does not independently establish dominant-negative mechanism","pmids":["32211516"],"is_preprint":false},{"year":2020,"finding":"The SCA34-causing W246G ELOVL4 knock-in rat shows selectively impaired VLC-SFA synthesis but preserved VLC-PUFA synthesis in retina and skin; homozygous rats develop reduced ERG a- and b-wave amplitudes without photoreceptor neurodegeneration, revealing a role for VLC-SFA in regulating retinal function independent of neurodegeneration.","method":"Knock-in rat model, GC/MS lipid analysis, ERG, OCT, histology, immunolabeling","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 1-2 — KI rat with lipidomics and multiple functional readouts; dissociates VLC-SFA from VLC-PUFA roles","pmids":["32780351"],"is_preprint":false},{"year":2021,"finding":"W246G mutant ELOVL4 rats show impaired motor function; cerebellar slice patch-clamp recordings reveal reduced LTP at parallel fiber-Purkinje cell synapses and reduced LTD at climbing fiber-Purkinje cell synapses, with no cerebellar neurodegeneration, establishing that SCA34 motor deficits arise from synaptic plasticity impairment.","method":"Knock-in rat model, cerebellar slice electrophysiology (LTP/LTD at PF-PC and CF-PC synapses), behavioral motor testing, neuroanatomical analysis","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 1-2 — electrophysiological analysis of specific synaptic plasticity mechanisms; links ELOVL4 to cerebellar synaptic function","pmids":["34227061"],"is_preprint":false},{"year":2022,"finding":"SCA34-causing ELOVL4 mutations L168F and W246G are deficient in VLC-SFA biosynthesis (especially W246G, which shows negligible VLC-SFA synthesis), while retaining VLC-PUFA biosynthetic capacity; L168F shows gain-of-function for certain VLC-PUFA species (38:5n3); selective VLC-SFA deficiency may underlie SCA34 and erythrokeratodermia pathology.","method":"Cell-based expression of WT, L168F, and W246G ELOVL4 variants with VLC-FA precursor supplementation, GC-MS lipid quantification","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic assay comparing multiple mutant variants to WT; identifies substrate-specific defects","pmids":["36464075"],"is_preprint":false},{"year":2023,"finding":"SCA34-causing ELOVL4 mutations (Q180P, T233M, W246G, I171T, L168F) produce shorter ultra-long-chain PUFA-containing phosphatidylcholines (ULC-PCs) than WT, consistent with incomplete elongation; modeled amino acid substitutions are in transmembrane helices that interact with the ω-end of the substrate acyl-CoA; heterozygous Q180P and homozygous W246G knock-in mouse ES cells show reduced neuronal ULC-PC production.","method":"Cell-based ULC-PC elongation assay, structural modeling, knock-in mouse ES cell neuronal differentiation, lipidomics","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — cell-based enzymatic assay with multiple SCA34 mutants, structural modeling, and KI ES cells; identifies molecular mechanism of SCA34 mutations","pmids":["36748939"],"is_preprint":false},{"year":2023,"finding":"W246G mutant ELOVL4 rat Purkinje cells show reduced mEPSC frequency (presynaptic defect), increased mIPSC frequency and amplitude, reduced paired-pulse ratio at PF-PC but increased at CF-PC synapses, exaggerated persistence of EPSC amplitude (larger readily releasable pool), and reduced dendritic spine density, identifying multiple specific presynaptic and postsynaptic mechanisms of synaptic dysfunction in SCA34.","method":"Patch-clamp recordings (mEPSC, mIPSC, PPR, high-frequency stimulation) from cerebellar Purkinje cells of SCA34-KI rats, dendritic spine morphometry","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 — detailed electrophysiological dissection of synaptic mechanisms; multiple recording paradigms","pmids":["37491316"],"is_preprint":false},{"year":2023,"finding":"ELOVL4 is a downstream target of the NOTCH-RIPK4-IRF6 signaling axis in skin; loss of Elovl4 alone is sufficient to trigger squamous cell carcinoma (SCC) development in autochthonous mouse models; overexpression of ELOVL4 suppresses tumor growth of Ripk4-deficient keratinocytes.","method":"Autochthonous mouse models (Pik3caH1047R oncogene with Ripk4/Irf6/Elovl4 conditional deletion), multiplexed in vivo CRISPR screening, transcriptional profiling, ELOVL4 overexpression rescue in Ripk4-deficient keratinocytes","journal":"Cancers","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in vivo with functional rescue; multiple in vivo models establish pathway position","pmids":["36765696"],"is_preprint":false},{"year":2021,"finding":"MYCN transcriptionally represses ELOVL4 in neuroblastoma cells; MYCN binds the ELOVL4 promoter in proximity to HDAC1, HDAC2, and Sp1 (shown by ChIP); ELOVL4 positively regulates neuronal differentiation and lipid droplet accumulation; MYCN silencing increases the ELOVL4 product FA34:6.","method":"ChIP (MYCN binding to ELOVL4 promoter), siRNA MYCN knockdown, in vitro differentiation with FA34:6 measurement, reporter assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP identifies MYCN as transcriptional repressor; single lab","pmids":["34333551"],"is_preprint":false},{"year":2023,"finding":"Novel ELOVL4 L168S variant causes deficiency in both VLC-SFA and VLC-PUFA biosynthesis (unlike L168F which retains VLC-PUFA synthesis), as demonstrated by cell-based expression with precursor supplementation; associated with early childhood-onset rapidly progressive SCA34 with macular dysfunction.","method":"Cell-based expression of L168S ELOVL4 variant with VLC-PUFA and VLC-SFA precursor supplementation, GC-MS lipid quantification","journal":"Acta neuropathologica communications","confidence":"Medium","confidence_rationale":"Tier 1 — direct enzymatic cell-based assay; single case/lab","pmids":["37568198"],"is_preprint":false},{"year":2025,"finding":"Contact cooling-induced ELOVL4 upregulation in wounded epidermis produces DHA and EPA that dampen TNFα and other pro-inflammatory cytokine expression, accelerating the transition from the inflammatory to the proliferative phase of wound healing; in vivo perturbation of ELOVL4 confirmed its functional requirement.","method":"Skin injury and skin organoid models, bulk/scRNA-seq, spatial transcriptomics, in vivo functional perturbation (ELOVL4 KD/OE), cytokine measurement","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo KD/OE with molecular readouts; single lab with multiple methods","pmids":["40083712"],"is_preprint":false},{"year":2026,"finding":"Testis-specific knockout of Elovl4 (Stra8-Cre) abolishes VLC-PUFA synthesis (>C26) in testes, causing abnormal spermatogenesis, reduced sperm count, sperm malformation, dramatic changes in Defbs gene family expression, decreased sperm motility, and severely reduced male fertility.","method":"Conditional KO mouse (Elovl4flox/flox, Stra8-Cre), GC/MS lipid analysis, spermatogenesis histology, sperm motility assay, fertility testing, RT-PCR and Western blot","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1-2 — conditional KO with biochemical and functional fertility readouts; establishes essential role of testicular ELOVL4/VLC-PUFA in male reproduction","pmids":["41495266"],"is_preprint":false}],"current_model":"ELOVL4 is an ER-resident fatty acid condensing enzyme (elongase) whose activity depends on conserved active-site histidines and the ER microenvironment, and which is uniquely responsible for synthesizing very long-chain saturated fatty acids (VLC-SFA, ≥C28) and very long-chain polyunsaturated fatty acids (VLC-PUFA, C28-C38) in a tissue-specific manner; its products are incorporated into phosphatidylcholines and ceramides/sphingolipids in the retina, brain, skin, meibomian glands, and testis, where they regulate photoreceptor membrane integrity, synaptic vesicle release kinetics and cerebellar plasticity, epidermal permeability barrier (via omega-O-acylceramides), tight junction stability in retinal vessels, and male fertility; disease-causing C-terminal truncation mutants lose the dilysine ER-retention signal, mislocalize to aggresomes/outer-segment disks, lack elongase catalytic activity, and exert dominant-negative sequestration of wild-type ELOVL4, while distinct missense mutations (SCA34) selectively impair VLC-SFA over VLC-PUFA synthesis, causing incomplete elongation of ultra-long-chain acyl-CoAs and synaptic dysfunction without acute neurodegeneration."},"narrative":{"teleology":[{"year":2001,"claim":"Identification of ELOVL4 as the STGD3 disease gene established that a photoreceptor-expressed protein with homology to yeast fatty acid elongases underlies autosomal dominant Stargardt-like macular dystrophy via a 5-bp deletion causing C-terminal truncation.","evidence":"Genetic mapping, recombination breakpoint analysis, direct sequencing, and bioinformatic homology in STGD3 families","pmids":["11138005"],"confidence":"High","gaps":["Enzymatic activity was not directly demonstrated","Mechanism of pathogenesis (loss-of-function vs. toxic gain-of-function) was unknown"]},{"year":2004,"claim":"Localization studies revealed that wild-type ELOVL4 resides in the ER via a C-terminal dilysine (KXKXX) retrieval motif, and that disease-causing truncations ablate this signal, causing mislocalization to aggregates or the Golgi, directly implicating ER residency in normal function.","evidence":"Immunofluorescence with organelle markers, immunoelectron microscopy in transfected COS-7, CHO, NIH-3T3, HEK293 cells and human photoreceptors","pmids":["15028284","15073583","15557430"],"confidence":"High","gaps":["Whether mislocalization per se or loss of enzymatic activity drives pathology was unresolved","The ER microenvironment requirement for catalysis had not been tested"]},{"year":2005,"claim":"The dominant-negative mechanism of STGD3 was established: truncated ELOVL4 physically interacts with and sequesters wild-type ELOVL4 into aggresome-like inclusions, forming higher-order oligomeric complexes and inducing the unfolded protein response.","evidence":"Co-immunoprecipitation, FRET, 2D gel electrophoresis, UPR marker analysis in COS-7 and HEK293T cells","pmids":["16036915","16163264","16145543"],"confidence":"High","gaps":["Whether WT sequestration occurs in photoreceptors in vivo was uncertain","Enzymatic activity of WT vs. mutant had not been measured directly"]},{"year":2007,"claim":"Knockout and knock-in mouse models proved that ELOVL4 is the sole enzyme responsible for synthesizing ≥C28 fatty acids in skin, and that loss of these VLC-FAs (particularly omega-O-acylceramides) collapses the epidermal permeability barrier, causing neonatal lethality.","evidence":"Elovl4 knockout and Stgd3 knock-in mice with lipid profiling, electron microscopy, and transepidermal water loss assays","pmids":["17208947","17311087","17304340"],"confidence":"High","gaps":["Brain and retinal phenotypes could not be assessed due to neonatal death","VLC-PUFA vs. VLC-SFA contributions were not separated"]},{"year":2007,"claim":"Lipidomic analysis of STGD3 knock-in retinas revealed selective depletion of C32–C36 acyl phosphatidylcholines without ER stress markers, suggesting product deficiency rather than ER stress as the primary retinal pathogenic mechanism.","evidence":"Mass spectrometry lipid profiling and ER stress marker analysis of Stgd3 knock-in mouse retinas","pmids":["17983602"],"confidence":"Medium","gaps":["Heterozygous model may not fully recapitulate disease severity","Protein toxicity vs. lipid loss was not definitively resolved"]},{"year":2008,"claim":"Direct enzymatic characterization proved that ELOVL4 is a fatty acid condensing enzyme that elongates C24:0 to C28–C30 saturated species and C20–C22 PUFAs to C28–C38 VLC-PUFAs, definitively establishing its biochemical function.","evidence":"Adenoviral Elovl4 expression in cardiomyocytes and ARPE-19 cells with fatty acid supplementation and GC-MS quantification","pmids":["18728184"],"confidence":"High","gaps":["Substrate specificity across different PUFA series was incompletely defined","Whether activity required ER localization was untested"]},{"year":2011,"claim":"Photoreceptor-specific conditional knockout demonstrated that ELOVL4 is essential for retinal VLC-PUFA-containing phosphatidylcholine synthesis and normal visual function, while epidermal transgenic rescue of neonatal lethality enabled study of tissue-specific roles.","evidence":"Cre-lox photoreceptor-specific KO with HPLC-MS lipidomics and ERG; involucrin-promoter transgenic rescue of Stgd3 homozygotes with lipid and barrier assays","pmids":["22199362","21429867"],"confidence":"High","gaps":["Whether VLC-PUFA loss alone is sufficient for photoreceptor degeneration was unclear","Brain-specific functions remained unexplored"]},{"year":2013,"claim":"Cell-free microsome assays confirmed that truncated ELOVL4 is catalytically dead and dominantly suppresses wild-type enzymatic activity; comparison of conditional KO mice (no degeneration despite VLC-PUFA loss) with STGD3 transgenic mice (degeneration) revealed that mutant protein toxicity, not mere VLC-PUFA deficiency, drives STGD3 retinal dystrophy.","evidence":"Cell-based and microsome condensation assays; rod- and cone-specific conditional KO vs. transgenic STGD3 mice with ERG, GC-MS, and electron microscopy","pmids":["23509295","23479632"],"confidence":"High","gaps":["The specific toxic mechanism of mislocalized mutant protein in photoreceptors was undefined","Whether VLC-PUFA loss contributes to long-term retinal vulnerability remained open"]},{"year":2014,"claim":"Active-site mutagenesis established that conserved histidine residues are required for ELOVL4 condensation activity and that ER displacement abolishes enzymatic function, proving the ER microenvironment is essential for catalysis; in Xenopus rods, the truncated mutant mislocalizes to outer segment disks.","evidence":"Overexpression of His-mutant and ER-retention-deficient ELOVL4 with GC-MS elongation assay; transgenic Xenopus photoreceptor imaging","pmids":["24569140","24833735"],"confidence":"High","gaps":["No crystal structure or detailed catalytic mechanism was available","Whether outer-segment disk mislocalization is directly toxic was not shown"]},{"year":2017,"claim":"Using skin-rescued Elovl4 mutant mice, ELOVL4-derived VLC-SFAs were shown to regulate synaptic vesicle release kinetics in hippocampal neurons; exogenous VLC-SFA supplementation rescued the defective release rate, establishing a direct role for ELOVL4 lipid products in neurotransmission.","evidence":"Skin-rescued double transgenic mice, hippocampal slice electrophysiology, FM1-43 synaptic vesicle release assay, VLC-SFA rescue experiment","pmids":["29168048"],"confidence":"High","gaps":["The molecular target of VLC-SFA at the synapse (membrane insertion, protein interaction) was unknown","Whether VLC-PUFA also contributes to synaptic function was untested"]},{"year":2018,"claim":"ELOVL4-derived VLC ceramides were shown to stabilize tight junctions in retinal vascular endothelium, with ELOVL4 overexpression reducing VEGF- and IL-1β-induced permeability and AAV-mediated delivery preventing diabetic retinal vascular leakage in vivo.","evidence":"ELOVL4 overexpression in endothelial cells, permeability assays, EM colocalization with TJ, intravitreal AAV2-hELOVL4 in diabetic mice","pmids":["29362226"],"confidence":"High","gaps":["The precise VLC-ceramide species responsible was not identified","Whether this mechanism operates in non-retinal vascular beds was unknown"]},{"year":2020,"claim":"The SCA34-causing W246G knock-in rat revealed that ELOVL4 missense mutations selectively impair VLC-SFA synthesis while preserving VLC-PUFA production, dissociating the two product classes and demonstrating that VLC-SFA deficiency alone impairs retinal function without neurodegeneration.","evidence":"W246G knock-in rat with GC/MS lipidomics, ERG, OCT, and histology","pmids":["32780351"],"confidence":"High","gaps":["How a single residue change creates substrate selectivity was structurally unresolved","Long-term neurodegeneration over the full lifespan was not fully assessed"]},{"year":2021,"claim":"Cerebellar electrophysiology in W246G rats established that SCA34 motor deficits arise from impaired synaptic plasticity—reduced LTP at parallel fiber–Purkinje cell synapses and reduced LTD at climbing fiber–Purkinje cell synapses—rather than from neurodegeneration.","evidence":"Cerebellar slice patch-clamp recordings of LTP and LTD, behavioral motor testing, neuroanatomical analysis in SCA34 knock-in rats","pmids":["34227061"],"confidence":"High","gaps":["Whether VLC-SFA supplementation rescues cerebellar plasticity deficits was not tested","The biophysical mechanism by which VLC-SFA modulates plasticity was undefined"]},{"year":2022,"claim":"Systematic comparison of SCA34 mutants (L168F, W246G) confirmed that each selectively impairs VLC-SFA biosynthesis while preserving (or even enhancing) VLC-PUFA synthesis, establishing substrate-specific catalytic defects as the molecular basis of SCA34.","evidence":"Cell-based expression of WT, L168F, and W246G ELOVL4 with VLC-FA precursor supplementation and GC-MS quantification","pmids":["36464075"],"confidence":"High","gaps":["No structural explanation for substrate-specific impairment was available","Whether VLC-SFA replacement therapy could treat SCA34 was untested"]},{"year":2023,"claim":"Multiple SCA34 mutations were mapped to transmembrane helices contacting the ω-end of the substrate acyl-CoA, and all produced incompletely elongated ultra-long-chain PUFA-containing phosphatidylcholines, providing the first structural-mechanistic explanation for SCA34 pathogenesis; detailed electrophysiology further identified pre- and postsynaptic defects including reduced mEPSC frequency, altered paired-pulse ratios, and reduced dendritic spine density in Purkinje cells.","evidence":"Cell-based ULC-PC elongation assay with five SCA34 mutants, structural modeling, knock-in ES cell neuronal differentiation lipidomics; patch-clamp recordings of mEPSC/mIPSC, PPR, and spine morphometry in SCA34-KI rat Purkinje cells","pmids":["36748939","37491316"],"confidence":"High","gaps":["No experimental 3D structure of ELOVL4 exists","Whether incomplete elongation products have toxic gain-of-function effects is unknown"]},{"year":2023,"claim":"ELOVL4 was positioned downstream of the NOTCH–RIPK4–IRF6 signaling axis in skin, and conditional Elovl4 deletion alone was sufficient to promote squamous cell carcinoma, revealing a tumor-suppressive function.","evidence":"Autochthonous mouse models with conditional deletion, multiplexed in vivo CRISPR screening, ELOVL4 overexpression rescue in Ripk4-deficient keratinocytes","pmids":["36765696"],"confidence":"High","gaps":["The tumor-suppressive mechanism (lipid product-mediated or cell-autonomous signaling) is uncharacterized","Relevance to human SCC is not established"]},{"year":2025,"claim":"Testis-specific Elovl4 knockout abolished VLC-PUFA synthesis in testes, causing abnormal spermatogenesis, sperm malformation, decreased motility, and severely reduced male fertility, establishing ELOVL4 as essential for male reproduction.","evidence":"Conditional KO mouse (Elovl4flox/flox; Stra8-Cre) with GC/MS lipid analysis, histology, sperm motility and fertility assays","pmids":["41495266"],"confidence":"High","gaps":["The specific sperm membrane lipid species responsible for motility defects are uncharacterized","Whether VLC-PUFA supplementation can rescue fertility is untested"]},{"year":null,"claim":"Key unresolved questions include the three-dimensional structure of ELOVL4 explaining substrate selectivity and SCA34 mutation effects, the molecular mechanism by which VLC-SFAs modulate synaptic vesicle fusion machinery and cerebellar plasticity, and whether lipid replacement therapies can rescue neurological or retinal disease phenotypes.","evidence":"","pmids":[],"confidence":"High","gaps":["No experimental structure of ELOVL4 or any ELOVL family member exists","The biophysical mechanism linking VLC-SFA/PUFA to synaptic vesicle release and plasticity is unknown","Therapeutic potential of VLC-FA supplementation or gene therapy for SCA34 and STGD3 is unexplored in clinical settings"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[11,14,16,18,29,30]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[11,14]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,2,3,6,18,19,22]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[7,8,11,14,15,29,30,36]}],"complexes":[],"partners":["ELOVL1","ELOVL2","ELOVL5","ELOVL6","ELOVL7"],"other_free_text":[]},"mechanistic_narrative":"ELOVL4 is an endoplasmic reticulum-resident fatty acid condensing enzyme (elongase) that uniquely catalyzes the synthesis of very long-chain saturated fatty acids (VLC-SFA, ≥C28) and very long-chain polyunsaturated fatty acids (VLC-PUFA, C28–C38) from C26 and shorter acyl-CoA precursors, with activity dependent on conserved active-site histidine residues and ER localization maintained by a C-terminal dilysine retrieval motif [PMID:18728184, PMID:24569140, PMID:15028284]. Its lipid products serve tissue-specific structural and signaling roles: omega-O-acylceramides are essential for the epidermal permeability barrier [PMID:17208947, PMID:21429867], VLC-PUFA-containing phosphatidylcholines support photoreceptor membrane integrity [PMID:22199362], VLC-ceramides stabilize retinal vascular tight junctions [PMID:29362226], VLC-SFAs regulate synaptic vesicle release kinetics and cerebellar synaptic plasticity [PMID:29168048, PMID:34227061], and testicular VLC-PUFAs are required for normal spermatogenesis and male fertility [PMID:41495266]. Dominant mutations causing autosomal dominant Stargardt-like macular dystrophy (STGD3) truncate the C-terminus, abolish elongase activity, and exert a dominant-negative effect by sequestering wild-type ELOVL4 into aggresomes, while distinct missense mutations causing spinocerebellar ataxia type 34 (SCA34) selectively impair VLC-SFA synthesis and produce incompletely elongated acyl chains, leading to synaptic dysfunction without acute neurodegeneration [PMID:23509295, PMID:16036915, PMID:36464075, PMID:36748939]."},"prefetch_data":{"uniprot":{"accession":"Q9GZR5","full_name":"Very long chain fatty acid elongase 4","aliases":["3-keto acyl-CoA synthase ELOVL4","ELOVL fatty acid elongase 4","ELOVL FA elongase 4","Elongation of very long chain fatty acids protein 4","Very long chain 3-ketoacyl-CoA synthase 4","Very long chain 3-oxoacyl-CoA synthase 4"],"length_aa":314,"mass_kda":36.8,"function":"Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that catalyzes the synthesis of very long chain saturated (VLC-SFA) and polyunsaturated (PUFA) fatty acids that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May play a critical role in early brain and skin development","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q9GZR5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ELOVL4","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ELOVL4","total_profiled":1310},"omim":[{"mim_id":"614457","title":"ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ISQMR","url":"https://www.omim.org/entry/614457"},{"mim_id":"611313","title":"ARMS2 GENE; ARMS2","url":"https://www.omim.org/entry/611313"},{"mim_id":"610698","title":"MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4","url":"https://www.omim.org/entry/610698"},{"mim_id":"607772","title":"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 1; PLEKHA1","url":"https://www.omim.org/entry/607772"},{"mim_id":"605512","title":"ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 4; ELOVL4","url":"https://www.omim.org/entry/605512"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":98.1},{"tissue":"retina","ntpm":163.6}],"url":"https://www.proteinatlas.org/search/ELOVL4"},"hgnc":{"alias_symbol":["CT118"],"prev_symbol":["STGD2","STGD3","SCA34"]},"alphafold":{"accession":"Q9GZR5","domains":[{"cath_id":"-","chopping":"76-271","consensus_level":"high","plddt":91.8241,"start":76,"end":271}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZR5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZR5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZR5-F1-predicted_aligned_error_v6.png","plddt_mean":83.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ELOVL4","jax_strain_url":"https://www.jax.org/strain/search?query=ELOVL4"},"sequence":{"accession":"Q9GZR5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9GZR5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9GZR5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZR5"}},"corpus_meta":[{"pmid":"11138005","id":"PMC_11138005","title":"A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy.","date":"2001","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11138005","citation_count":364,"is_preprint":false},{"pmid":"18728184","id":"PMC_18728184","title":"Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18728184","citation_count":222,"is_preprint":false},{"pmid":"17208947","id":"PMC_17208947","title":"Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17208947","citation_count":214,"is_preprint":false},{"pmid":"22100072","id":"PMC_22100072","title":"Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia.","date":"2011","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22100072","citation_count":156,"is_preprint":false},{"pmid":"15749821","id":"PMC_15749821","title":"Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15749821","citation_count":152,"is_preprint":false},{"pmid":"11726641","id":"PMC_11726641","title":"Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene.","date":"2001","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11726641","citation_count":134,"is_preprint":false},{"pmid":"17311087","id":"PMC_17311087","title":"Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice.","date":"2007","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17311087","citation_count":134,"is_preprint":false},{"pmid":"20299492","id":"PMC_20299492","title":"Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/20299492","citation_count":132,"is_preprint":false},{"pmid":"17304340","id":"PMC_17304340","title":"Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival.","date":"2007","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17304340","citation_count":121,"is_preprint":false},{"pmid":"19875612","id":"PMC_19875612","title":"Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4.","date":"2009","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/19875612","citation_count":112,"is_preprint":false},{"pmid":"24566826","id":"PMC_24566826","title":"Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia.","date":"2014","source":"JAMA neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24566826","citation_count":99,"is_preprint":false},{"pmid":"31616255","id":"PMC_31616255","title":"Novel Cellular Functions of Very Long Chain-Fatty Acids: Insight From ELOVL4 Mutations.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31616255","citation_count":87,"is_preprint":false},{"pmid":"20601113","id":"PMC_20601113","title":"Expression and role of Elovl4 elongases in biosynthesis of very long-chain fatty acids during zebrafish Danio rerio early embryonic development.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20601113","citation_count":82,"is_preprint":false},{"pmid":"15028285","id":"PMC_15028285","title":"Characterization of mouse orthologue of ELOVL4: genomic organization and spatial and temporal expression.","date":"2004","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15028285","citation_count":79,"is_preprint":false},{"pmid":"15557430","id":"PMC_15557430","title":"A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15557430","citation_count":78,"is_preprint":false},{"pmid":"22199362","id":"PMC_22199362","title":"Essential role of ELOVL4 protein in very long chain fatty acid synthesis and retinal function.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22199362","citation_count":76,"is_preprint":false},{"pmid":"16036915","id":"PMC_16036915","title":"Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16036915","citation_count":74,"is_preprint":false},{"pmid":"26010696","id":"PMC_26010696","title":"A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34.","date":"2015","source":"JAMA neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26010696","citation_count":70,"is_preprint":false},{"pmid":"30982505","id":"PMC_30982505","title":"ELOVL4: Very long-chain fatty acids serve an eclectic role in mammalian health and function.","date":"2018","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/30982505","citation_count":68,"is_preprint":false},{"pmid":"21377536","id":"PMC_21377536","title":"Biosynthesis of very long-chain fatty acids (C>24) in Atlantic salmon: cloning, functional characterisation, and tissue distribution of an Elovl4 elongase.","date":"2011","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21377536","citation_count":64,"is_preprint":false},{"pmid":"33556440","id":"PMC_33556440","title":"Very long chain fatty acid-containing lipids: a decade of novel insights from the study of ELOVL4.","date":"2021","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/33556440","citation_count":60,"is_preprint":false},{"pmid":"17983602","id":"PMC_17983602","title":"A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17983602","citation_count":56,"is_preprint":false},{"pmid":"31316480","id":"PMC_31316480","title":"Taxonomy and Broad-Spectrum Antifungal Activity of Streptomyces sp. SCA3-4 Isolated From Rhizosphere Soil of Opuntia stricta.","date":"2019","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31316480","citation_count":56,"is_preprint":false},{"pmid":"16145543","id":"PMC_16145543","title":"Loss of ER retention and sequestration of the wild-type ELOVL4 by Stargardt disease dominant negative mutants.","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16145543","citation_count":55,"is_preprint":false},{"pmid":"16163264","id":"PMC_16163264","title":"Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes.","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16163264","citation_count":54,"is_preprint":false},{"pmid":"22158834","id":"PMC_22158834","title":"ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3.","date":"2011","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22158834","citation_count":54,"is_preprint":false},{"pmid":"15028284","id":"PMC_15028284","title":"Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.","date":"2004","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15028284","citation_count":52,"is_preprint":false},{"pmid":"17003453","id":"PMC_17003453","title":"Elovl4 5-bp-deletion knock-in mice develop progressive photoreceptor degeneration.","date":"2006","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/17003453","citation_count":52,"is_preprint":false},{"pmid":"21873315","id":"PMC_21873315","title":"Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration.","date":"2011","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/21873315","citation_count":48,"is_preprint":false},{"pmid":"23479632","id":"PMC_23479632","title":"Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23479632","citation_count":48,"is_preprint":false},{"pmid":"24677106","id":"PMC_24677106","title":"A role for ELOVL4 in the mouse meibomian gland and sebocyte cell biology.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24677106","citation_count":46,"is_preprint":false},{"pmid":"29417145","id":"PMC_29417145","title":"Stargardt Phenotype Associated With Two ELOVL4 Promoter Variants and ELOVL4 Downregulation: New Possible Perspective to Etiopathogenesis?","date":"2018","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/29417145","citation_count":46,"is_preprint":false},{"pmid":"26112824","id":"PMC_26112824","title":"Polyunsaturated fatty acid metabolism in a marine teleost, Nibe croaker Nibea mitsukurii: Functional characterization of Fads2 desaturase and Elovl5 and Elovl4 elongases.","date":"2015","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26112824","citation_count":43,"is_preprint":false},{"pmid":"23509295","id":"PMC_23509295","title":"Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23509295","citation_count":40,"is_preprint":false},{"pmid":"16877435","id":"PMC_16877435","title":"Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.","date":"2006","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/16877435","citation_count":40,"is_preprint":false},{"pmid":"29362226","id":"PMC_29362226","title":"ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.","date":"2018","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/29362226","citation_count":40,"is_preprint":false},{"pmid":"12847421","id":"PMC_12847421","title":"Elovl4 mRNA distribution in the developing mouse retina and phylogenetic conservation of Elovl4 genes.","date":"2003","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/12847421","citation_count":39,"is_preprint":false},{"pmid":"19682985","id":"PMC_19682985","title":"Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin.","date":"2009","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/19682985","citation_count":37,"is_preprint":false},{"pmid":"15073583","id":"PMC_15073583","title":"Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability.","date":"2004","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/15073583","citation_count":36,"is_preprint":false},{"pmid":"29168048","id":"PMC_29168048","title":"Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/29168048","citation_count":35,"is_preprint":false},{"pmid":"11803489","id":"PMC_11803489","title":"Evaluation of the ELOVL4 gene in patients with age-related macular degeneration.","date":"2001","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11803489","citation_count":35,"is_preprint":false},{"pmid":"19536303","id":"PMC_19536303","title":"DHA does not protect ELOVL4 transgenic mice from retinal degeneration.","date":"2009","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/19536303","citation_count":32,"is_preprint":false},{"pmid":"16476896","id":"PMC_16476896","title":"Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation.","date":"2006","source":"Archives of ophthalmology (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/16476896","citation_count":32,"is_preprint":false},{"pmid":"21429867","id":"PMC_21429867","title":"Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.","date":"2011","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/21429867","citation_count":31,"is_preprint":false},{"pmid":"31750392","id":"PMC_31750392","title":"A family with spinocerebellar ataxia and retinitis pigmentosa attributed to an ELOVL4 mutation.","date":"2019","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31750392","citation_count":31,"is_preprint":false},{"pmid":"24571530","id":"PMC_24571530","title":"A novel recessive mutation in the gene ELOVL4 causes a neuro-ichthyotic disorder with variable expressivity.","date":"2014","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24571530","citation_count":30,"is_preprint":false},{"pmid":"28507511","id":"PMC_28507511","title":"Distribution of ELOVL4 in the Developing and Adult Mouse Brain.","date":"2017","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/28507511","citation_count":29,"is_preprint":false},{"pmid":"32211516","id":"PMC_32211516","title":"Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34.","date":"2020","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32211516","citation_count":26,"is_preprint":false},{"pmid":"17254625","id":"PMC_17254625","title":"Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice.","date":"2007","source":"Vision research","url":"https://pubmed.ncbi.nlm.nih.gov/17254625","citation_count":26,"is_preprint":false},{"pmid":"26427403","id":"PMC_26427403","title":"Different Mutations in ELOVL4 Affect Very Long Chain Fatty Acid Biosynthesis to Cause Variable Neurological Disorders in Humans.","date":"2016","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/26427403","citation_count":25,"is_preprint":false},{"pmid":"24569140","id":"PMC_24569140","title":"Endoplasmic reticulum microenvironment and conserved histidines govern ELOVL4 fatty acid elongase activity.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/24569140","citation_count":24,"is_preprint":false},{"pmid":"28668330","id":"PMC_28668330","title":"Molecular and functional characterisation of two elovl4 elongases involved in the biosynthesis of very long-chain (>C24) polyunsaturated fatty acids in black seabream Acanthopagrus schlegelii.","date":"2017","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28668330","citation_count":24,"is_preprint":false},{"pmid":"21139992","id":"PMC_21139992","title":"Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.","date":"2010","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/21139992","citation_count":23,"is_preprint":false},{"pmid":"34725421","id":"PMC_34725421","title":"Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34725421","citation_count":20,"is_preprint":false},{"pmid":"22948568","id":"PMC_22948568","title":"Evaluation of the ELOVL4, PRPH2 and ABCA4 genes in patients with Stargardt macular degeneration.","date":"2012","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/22948568","citation_count":19,"is_preprint":false},{"pmid":"24833735","id":"PMC_24833735","title":"Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24833735","citation_count":19,"is_preprint":false},{"pmid":"29724783","id":"PMC_29724783","title":"Elovl4 and Fa2h expression during rat spermatogenesis: a link to the very-long-chain PUFAs typical of germ cell sphingolipids.","date":"2018","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/29724783","citation_count":18,"is_preprint":false},{"pmid":"36464075","id":"PMC_36464075","title":"ELOVL4 Mutations That Cause Spinocerebellar Ataxia-34 Differentially Alter Very Long Chain Fatty Acid Biosynthesis.","date":"2022","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/36464075","citation_count":17,"is_preprint":false},{"pmid":"32186869","id":"PMC_32186869","title":"Two Elongases, Elovl4 and Elovl6, Fulfill the Elongation Routes of the LC-PUFA Biosynthesis Pathway in the Orange Mud Crab (Scylla olivacea).","date":"2020","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32186869","citation_count":17,"is_preprint":false},{"pmid":"32780351","id":"PMC_32780351","title":"The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.","date":"2020","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/32780351","citation_count":16,"is_preprint":false},{"pmid":"36765696","id":"PMC_36765696","title":"The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36765696","citation_count":16,"is_preprint":false},{"pmid":"34333551","id":"PMC_34333551","title":"The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34333551","citation_count":16,"is_preprint":false},{"pmid":"29377748","id":"PMC_29377748","title":"Long-term follow-up of autosomal dominant Stargardt macular dystrophy (STGD3) subjects enrolled in a fish oil supplement interventional trial.","date":"2018","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29377748","citation_count":16,"is_preprint":false},{"pmid":"28856549","id":"PMC_28856549","title":"Elongation of very Long-Chain (>C24) Fatty Acids in Clarias gariepinus: Cloning, Functional Characterization and Tissue Expression of elovl4 Elongases.","date":"2017","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/28856549","citation_count":16,"is_preprint":false},{"pmid":"29287723","id":"PMC_29287723","title":"Elovl4 can effectively elongate C18 polyunsaturated fatty acids in loach Misgurnus anguillicaudatus.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29287723","citation_count":16,"is_preprint":false},{"pmid":"31669375","id":"PMC_31669375","title":"Molecular and functional characterisation of a putative elovl4 gene and its expression in response to dietary fatty acid profile in Atlantic bluefin tuna (Thunnus thynnus).","date":"2019","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31669375","citation_count":16,"is_preprint":false},{"pmid":"29654292","id":"PMC_29654292","title":"Photoreceptor-induced RPE phagolysosomal maturation defects in Stargardt-like Maculopathy (STGD3).","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29654292","citation_count":15,"is_preprint":false},{"pmid":"19933199","id":"PMC_19933199","title":"Inner retina remodeling in a mouse model of stargardt-like macular dystrophy (STGD3).","date":"2009","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/19933199","citation_count":15,"is_preprint":false},{"pmid":"34227061","id":"PMC_34227061","title":"W246G Mutant ELOVL4 Impairs Synaptic Plasticity in Parallel and Climbing Fibers and Causes Motor Defects in a Rat Model of SCA34.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/34227061","citation_count":15,"is_preprint":false},{"pmid":"29277642","id":"PMC_29277642","title":"Cloning, tissue distribution and nutritional regulation of a fatty acyl Elovl4-like elongase in mud crab, Scylla paramamosain (Estampador, 1949).","date":"2017","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29277642","citation_count":15,"is_preprint":false},{"pmid":"24664730","id":"PMC_24664730","title":"Dominant Stargardt Macular Dystrophy (STGD3) and ELOVL4.","date":"2014","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24664730","citation_count":14,"is_preprint":false},{"pmid":"26529045","id":"PMC_26529045","title":"Early Onset Ultrastructural and Functional Defects in RPE and Photoreceptors of a Stargardt-Like Macular Dystrophy (STGD3) Transgenic Mouse Model.","date":"2015","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/26529045","citation_count":14,"is_preprint":false},{"pmid":"20238022","id":"PMC_20238022","title":"Role of Elovl4 protein in the biosynthesis of docosahexaenoic acid.","date":"2010","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/20238022","citation_count":14,"is_preprint":false},{"pmid":"12806887","id":"PMC_12806887","title":"Molecular cloning of ELOVL4 gene from cynomolgus monkey (Macaca fascicularis).","date":"2003","source":"Experimental animals","url":"https://pubmed.ncbi.nlm.nih.gov/12806887","citation_count":14,"is_preprint":false},{"pmid":"24334447","id":"PMC_24334447","title":"Long-term retinal cone survival and delayed alteration of the cone mosaic in a transgenic mouse model of stargardt-like dystrophy (STGD3).","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24334447","citation_count":14,"is_preprint":false},{"pmid":"32429178","id":"PMC_32429178","title":"Molecular and Functional Characterization of Elovl4 Genes in Sparus aurata and Solea senegalensis Pointing to a Critical Role in Very Long-Chain (>C24) Fatty Acid Synthesis during Early Neural Development of Fish.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32429178","citation_count":13,"is_preprint":false},{"pmid":"31958500","id":"PMC_31958500","title":"Cloning and functional characterization of an elovl4-like gene involved in the biosynthesis of long-chain polyunsaturated fatty acids in the swimming crab Portunus trituberculatus.","date":"2020","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31958500","citation_count":13,"is_preprint":false},{"pmid":"33652762","id":"PMC_33652762","title":"Two Italian Patients with ELOVL4-Related Neuro-Ichthyosis:  Expanding the Genotypic and Phenotypic Spectrum and Ultrastructural Characterization.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33652762","citation_count":11,"is_preprint":false},{"pmid":"37491316","id":"PMC_37491316","title":"Synapse-Specific Defects in Synaptic Transmission in the Cerebellum of W246G Mutant ELOVL4 Rats-a Model of Human SCA34.","date":"2023","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37491316","citation_count":10,"is_preprint":false},{"pmid":"24644051","id":"PMC_24644051","title":"In vivo effect of mutant ELOVL4 on the expression and function of wild-type ELOVL4.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24644051","citation_count":10,"is_preprint":false},{"pmid":"34689836","id":"PMC_34689836","title":"Neuropathology of SCA34 showing widespread oligodendroglial pathology with vacuolar white matter degeneration: a case study.","date":"2021","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/34689836","citation_count":9,"is_preprint":false},{"pmid":"12592226","id":"PMC_12592226","title":"Evaluation of the ELOVL4 gene in patients with autosomal recessive retinitis pigmentosa and Leber congenital amaurosis.","date":"2003","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/12592226","citation_count":9,"is_preprint":false},{"pmid":"24664752","id":"PMC_24664752","title":"Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.","date":"2014","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24664752","citation_count":8,"is_preprint":false},{"pmid":"37568198","id":"PMC_37568198","title":"A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.","date":"2023","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/37568198","citation_count":7,"is_preprint":false},{"pmid":"36748939","id":"PMC_36748939","title":"Incomplete Elongation of Ultra-long-chain Polyunsaturated Acyl-CoAs by the Fatty Acid Elongase ELOVL4 in Spinocerebellar Ataxia Type 34.","date":"2023","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36748939","citation_count":6,"is_preprint":false},{"pmid":"37592902","id":"PMC_37592902","title":"Expanding the allelic spectrum of ELOVL4-related autosomal recessive neuro-ichthyosis.","date":"2023","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37592902","citation_count":6,"is_preprint":false},{"pmid":"29293603","id":"PMC_29293603","title":"Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29293603","citation_count":6,"is_preprint":false},{"pmid":"12967813","id":"PMC_12967813","title":"Autosomal dominant Stargardt-like macular dystrophy: identification of a new family with a mutation in the ELOVL4 gene.","date":"2003","source":"American journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/12967813","citation_count":5,"is_preprint":false},{"pmid":"37184663","id":"PMC_37184663","title":"SCA34 caused by ELOVL4 L168F mutation is a lysosomal lipid storage disease sharing pathology features with neuronal ceroid lipofuscinosis and peroxisomal disorders.","date":"2023","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/37184663","citation_count":5,"is_preprint":false},{"pmid":"16364203","id":"PMC_16364203","title":"Evaluation of the ELOVL4 gene in a Chinese family with autosomal dominant STGD3-like macular dystrophy.","date":"2005","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16364203","citation_count":4,"is_preprint":false},{"pmid":"40083712","id":"PMC_40083712","title":"Contact Cooling-Induced ELOVL4 Enhances Skin Wound Healing by Promoting the Inflammation-to-Proliferation Phase Transition.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40083712","citation_count":3,"is_preprint":false},{"pmid":"36002420","id":"PMC_36002420","title":"[Construction of a testis Elovl4 gene knockout mouse model based on Cre/loxP system].","date":"2022","source":"Sheng wu gong cheng xue bao = Chinese journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36002420","citation_count":1,"is_preprint":false},{"pmid":"20388345","id":"PMC_20388345","title":"[Association of M299V variant in ELOVL4 gene with exudative age-related macular degeneration in a Chinese population].","date":"2010","source":"[Zhonghua yan ke za zhi] Chinese journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/20388345","citation_count":1,"is_preprint":false},{"pmid":"38850484","id":"PMC_38850484","title":"The Spinocerebellar Ataxia 34-Causing W246G ELOVL4 Mutation Does Not Alter Cerebellar Neuron Populations in a Rat Model.","date":"2024","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/38850484","citation_count":0,"is_preprint":false},{"pmid":"32916248","id":"PMC_32916248","title":"Functional characterization, tissue distribution and nutritional regulation of the Elovl4 gene in golden pompano, Trachinotus ovatus (Linnaeus, 1758).","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32916248","citation_count":0,"is_preprint":false},{"pmid":"41495266","id":"PMC_41495266","title":"Testis-specific knockout of Elovl4 reduces sperm motility and fertility in male mice.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41495266","citation_count":0,"is_preprint":false},{"pmid":"36623811","id":"PMC_36623811","title":"Acral collodion membrane associated with ichthyosis due to a heterozygous pathogenic variant of ELOVL4 gene.","date":"2023","source":"Pediatric dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/36623811","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.15.682296","title":"Establishment of spinocerebellar ataxia type 34 model mice accompanied by early glial activation and degeneration of cerebellar neurons","date":"2025-10-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.15.682296","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.23.595617","title":"Enzymes enabling the biosynthesis of various C<sub>20</sub>polyunsaturated fatty acids in a sea urchin<i>Hemicentrotus pulcherrimus</i>","date":"2024-05-24","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.23.595617","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54334,"output_tokens":9100,"usd":0.149751},"stage2":{"model":"claude-opus-4-6","input_tokens":12926,"output_tokens":4540,"usd":0.267195},"total_usd":0.416946,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"ELOVL4 encodes a retinal photoreceptor-specific protein with homology to yeast proteins involved in very long-chain fatty acid biosynthesis; a 5-bp deletion causing C-terminal truncation segregates with autosomal dominant Stargardt-like macular dystrophy (STGD3) and adMD.\",\n      \"method\": \"Genetic mapping, recombination breakpoint analysis, direct sequencing, bioinformatic homology analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational discovery paper with genetic mapping and sequencing; strongly replicated across multiple subsequent studies\",\n      \"pmids\": [\"11138005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Wild-type ELOVL4 localizes predominantly to the endoplasmic reticulum (ER) via a C-terminal dilysine (KXKXX) ER-retention/retrieval motif; disease-associated mutations that truncate the C-terminus cause mislocalization to the Golgi in COS-7 and CHO cells, and similarly to the ER in human photoreceptors.\",\n      \"method\": \"Immunofluorescence with organelle markers, immunoelectron microscopy in transfected cells and human photoreceptors\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with multiple organelle markers, replicated by multiple independent labs\",\n      \"pmids\": [\"15028284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Wild-type ELOVL4 fused to EGFP localizes to the ER; the C-terminally truncated mutant mislocalizes to cytoplasmic aggregates and induces apoptotic cell death in transfected cells.\",\n      \"method\": \"Confocal fluorescence microscopy with ER/mitochondria/peroxisome/Golgi markers, TUNEL staining in NIH 3T3 and HEK293 cells\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple organelle markers used; single lab, consistent with other localization studies\",\n      \"pmids\": [\"15073583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"A novel Y270X stop mutation in ELOVL4 causes mislocalization of the mutant protein away from the ER in transfected NIH-3T3 and HEK293 cells, consistent with loss of the C-terminal ER-retention signal.\",\n      \"method\": \"EGFP fusion protein transfection, confocal microscopy co-localized with ER marker (pDsRed2-ER)\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment; single lab but consistent with multiple other studies\",\n      \"pmids\": [\"15557430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Disease-associated C-terminal truncation mutants of ELOVL4 accumulate in aggresome-like juxtanuclear inclusions; when co-expressed, mutant ELOVL4 physically interacts with and sequesters wild-type ELOVL4 into these aggresomes, demonstrating a dominant-negative mechanism.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence in COS-7 and HEK293T cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP and localization; independently replicated by multiple groups\",\n      \"pmids\": [\"16036915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ELOVL4 mutant protein (5-bp deletion) interacts with wild-type ELOVL4 to form higher molecular mass complexes that accumulate in perinuclear aggresomes, as shown by 2D gel electrophoresis and FRET analysis; mutant protein expression also induces unfolded protein response (BiP and CHOP upregulation).\",\n      \"method\": \"Immunocytochemistry, 2D gel electrophoresis, FRET, western blotting in COS-7 cells\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (FRET, 2D-gel, ICC); corroborates dominant-negative mechanism\",\n      \"pmids\": [\"16163264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ELOVL4 mutants lose ER retention and sequester wild-type ELOVL4 into cytoplasmic aggregates; deletion of the ER retention signal (KAKGD→5A) from wild-type ELOVL4 recapitulates mislocalization; mutant expression induces UPR markers BiP and CHOP.\",\n      \"method\": \"Fluorescence microscopy, co-immunoprecipitation, sucrose gradient fractionation, western blot in HEK293 and COS cells\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods; demonstrates ER-retention signal requirement functionally\",\n      \"pmids\": [\"16145543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Homozygous loss of ELOVL4 (knock-in 5-bp deletion or full knockout) in mice causes global depletion of very long-chain fatty acids (≥C28) in the epidermis, loss of omega-O-acylceramides, defective lamellar body secretion, disrupted stratum corneum lamellar membranes, and consequent neonatal lethality due to failed epidermal permeability barrier.\",\n      \"method\": \"Knock-in/knockout mouse model, lipid analysis (ceramide/glucosylceramide fractions), electron microscopy of skin ultrastructure, permeability barrier assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mouse KO/KI with biochemical lipid analysis and ultrastructural phenotype; replicated by at least two independent labs\",\n      \"pmids\": [\"17208947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ELOVL4 knockout (Elovl4-/-) mice lack ceramides with omega-hydroxy very long-chain fatty acids (≥C28), accumulate C26-containing ceramides (implicating C26 as an ELOVL4 substrate), and die postnatally from defective skin water permeability barrier, confirming ELOVL4 is required for C28+ fatty acid synthesis essential for skin barrier.\",\n      \"method\": \"Gene knockout mouse model, lipid analysis, skin histology, electron microscopy, transepidermal water loss measurement\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — KO mouse with biochemical and ultrastructural data; independently confirms findings in PMID 17208947\",\n      \"pmids\": [\"17311087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Elovl4 Y270X and complete knockout mice die perinatally from dehydration due to defective epidermal permeability barrier; biochemical analysis reveals a significant reduction in free fatty acids longer than C26 in homozygous mutant skin, establishing ELOVL4 as an elongase of C26+ fatty acids.\",\n      \"method\": \"Knock-in/knockout mouse models, fatty acid profiling of skin, transepidermal water loss measurement\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO/KI mouse with biochemical lipid analysis; independent replication of epidermal phenotype\",\n      \"pmids\": [\"17304340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Stgd3 knock-in mouse retinas show selective deficiency of C32-C36 acyl phosphatidylcholines but no cellular stress response, indicating that lipid product deficiency (rather than ER stress) is the primary pathogenic mechanism in STGD3 retina.\",\n      \"method\": \"Mass spectrometry (lipid profiling) of retina from Stgd3 knock-in mice, ER stress marker analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knock-in mouse with lipidomics; single lab\",\n      \"pmids\": [\"17983602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ELOVL4 is a fatty acid condensing enzyme directly responsible for synthesis of C28-C30 saturated VLC-FA and C28-C38 VLC-PUFA; gain-of-function adenoviral expression of mouse Elovl4 in cardiomyocytes and ARPE-19 cells supplemented with 24:0, 20:5n3, or 22:5n3 produced elongated products up to C30 (saturated) or C38 (PUFA).\",\n      \"method\": \"Gain-of-function adenoviral transduction of Elovl4 in cell lines, fatty acid supplementation, GC-MS lipid analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic gain-of-function assay in cells with substrate supplementation; foundational paper establishing elongase activity\",\n      \"pmids\": [\"18728184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ELOVL4 protein is not involved in DHA (22:6n3) biosynthesis from short-chain precursors (18:3n3 and 22:5n3), as shown by siRNA knockdown in cone photoreceptor-derived 661w cells.\",\n      \"method\": \"siRNA knockdown of ELOVL4 in 661w cells with fatty acid precursor labeling\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in relevant cell type with specific substrate testing; single lab\",\n      \"pmids\": [\"20238022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Photoreceptor-specific conditional knockout of Elovl4 in mice causes significant depletion of retinal glycerophospholipids containing VLC-PUFAs (particularly in the sn-1 position of phosphatidylcholine), abnormal lipid droplet and lipofuscin-like granule accumulation, and photoreceptor-specific defects in visual response by ERG.\",\n      \"method\": \"Cre-lox photoreceptor-specific KO mouse, HPLC-MS lipidomics, immunofluorescence, histology, electroretinography\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — conditional KO with lipidomics and functional ERG readout; establishes essential role of ELOVL4 in retinal VLC-PUFA synthesis and function\",\n      \"pmids\": [\"22199362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ELOVL4 preferentially elongates 20:5n3 (EPA) over 20:4n6 or 22:6n3 to produce C28-C38 VLC-PUFA; C34 and C36 VLC-PUFAs are the predominant products; only ELOVL4-expressing cells (not controls) synthesize VLC-PUFA ≥C28 from these precursors.\",\n      \"method\": \"Adenoviral ELOVL4 expression in PC12 cells, fatty acid supplementation, GC-MS lipid analysis\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cell-based enzymatic assay with multiple substrates tested; defines substrate preference\",\n      \"pmids\": [\"22158834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Epidermal-targeted transgenic expression of wild-type Elovl4 (involucrin promoter) rescues neonatal lethality of homozygous Stgd3 mice, restoring epidermal C28-C36 acylceramides and (O-linoleoyl)-omega-hydroxy C28-C36 fatty acids and skin barrier function, establishing that epidermal ELOVL4-mediated VLC-FA synthesis is essential for survival.\",\n      \"method\": \"Transgenic rescue experiment, lipid analysis, skin barrier function assay\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — transgenic rescue with biochemical validation; definitively establishes tissue-specific function\",\n      \"pmids\": [\"21429867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The STGD3-associated C-terminally truncated ELOVL4 mutant lacks intrinsic condensation (elongase) activity in both cell-based and cell-free microsome assays, and co-expression with wild-type ELOVL4 causes dominant-negative suppression of wild-type ELOVL4 localization and enzymatic activity, reducing VLC-PUFA synthesis.\",\n      \"method\": \"Cell-based and cell-free microsome condensation assays, co-expression experiments, VLC-PUFA quantification by GC-MS\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with mutagenesis/truncation variants + cell-free microsome assay; directly demonstrates catalytic loss and dominant-negative enzymatic effect\",\n      \"pmids\": [\"23509295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Rod-specific and cone-specific conditional Elovl4 knockout mice show near-total loss of retinal C30-C34 VLC-PUFAs without electrophysiological or behavioral deficits, whereas transgenic mice expressing the human STGD3 mutant ELOVL4 allele develop typical rod-cone dystrophy despite similar VLC-PUFA depletion, suggesting mutant protein toxicity (not VLC-PUFA loss alone) drives the STGD3 phenotype.\",\n      \"method\": \"Conditional KO and transgenic mouse models, GC-MS (VLC-PUFA and A2E measurement), ERG, electron microscopy, optomotor tracking\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple genetically distinct mouse models with multiple functional readouts; resolves mechanism debate\",\n      \"pmids\": [\"23479632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ELOVL4 elongase activity requires: (1) its localization to the ER microenvironment (displacement from ER abolishes condensation activity); (2) specific active-site histidine residues (His mutants lose elongase activity); N-glycosylation is dispensable for enzyme function.\",\n      \"method\": \"Overexpression of full-length, N-glycosylation-deficient, ER-retention mutant, and active-site histidine mutants of ELOVL4 with VLC-FA elongation assay by GC-MS\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — active-site mutagenesis combined with in-cell enzymatic assay; identifies catalytic residues and ER requirement\",\n      \"pmids\": [\"24569140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In transgenic Xenopus laevis rod photoreceptors, wild-type ELOVL4 localizes primarily to inner segments; the disease-linked C-terminal truncation mutant (lacking the dilysine ER-retention motif) mislocalizes to post-Golgi compartments and outer segment disks; co-expression of mutant and WT ELOVL4 does not cause mislocalization or aggregation of WT protein in rods in vivo.\",\n      \"method\": \"Transgenic Xenopus laevis rod photoreceptor expression, immunofluorescence and direct fluorescence microscopy\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo localization in native photoreceptors with functional relevance to disease mechanism\",\n      \"pmids\": [\"24833735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ELOVL4 is expressed in meibomian gland and sebaceous gland holocrine cells, localizing to structures surrounding lipid deposits; Stgd3 mutant mice show meibomian gland abnormalities including protruding orifices and altered gland anatomy resembling evaporative dry eye, implicating ELOVL4-derived VLC-FAs in meibum composition.\",\n      \"method\": \"Immunohistochemistry in eyelid tissue, histology (H&E), phenotypic assessment in Stgd3 mice\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization in tissue with functional phenotypic consequence in mutant mice; single lab\",\n      \"pmids\": [\"24677106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The ELOVL4ΔC (truncation) mutant forms homo-oligomers more strongly than wild-type ELOVL4 and also interacts via hetero-oligomerization with other elongases (ELOVL1-7) and with other VLCFA elongation machinery components, suggesting that ELOVL4ΔC disrupts the entire VLCFA elongation pathway through broad hetero-oligomeric interactions.\",\n      \"method\": \"Co-immunoprecipitation of ELOVL4ΔC with elongases ELOVL1-7 and other elongation complex components in HEK293T cells\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP with multiple partners; single lab; expands mechanistic understanding of dominant-negative effect\",\n      \"pmids\": [\"21139992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ELOVL4 expression in the brain is restricted primarily to neurons (not astrocytes or radial glia), with expression beginning by embryonic day 18 and persisting in adult cerebral cortex, hippocampus, cerebellum, thalamus, hypothalamus, midbrain, pons, and medulla; some oligodendrocytes in white matter also express ELOVL4; subcellular localization is restricted to cell bodies consistent with ER residence.\",\n      \"method\": \"Immunolabeling with cell-type-specific markers (NeuN, GFAP, Olig2, etc.) in mouse brain sections from E18 to P60\",\n      \"journal\": \"Frontiers in neuroanatomy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — systematic immunolabeling across developmental stages; single lab\",\n      \"pmids\": [\"28507511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Homozygous expression of the STGD3 Elovl4 mutation (with skin-specific WT rescue) causes seizures by P19 and death by P21 in mice; hippocampal slices show aberrant epileptogenic activity; cultured hippocampal neurons exhibit accelerated synaptic vesicle release kinetics (FM1-43 assay); supplementation with VLC-SFA rescues defective synaptic release to WT rates, establishing that ELOVL4's VLC-SFA products regulate synaptic release kinetics.\",\n      \"method\": \"Double transgenic mouse model with skin rescue, hippocampal slice electrophysiology, FM1-43 dye release assay, VLC-SFA supplementation rescue experiment\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including functional rescue with VLC-SFA; directly links ELOVL4 products to synaptic release kinetics\",\n      \"pmids\": [\"29168048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ELOVL4-derived VLC ceramides (≥C26) stabilize tight junctions in retinal vascular endothelium; ELOVL4 overexpression decreases basal permeability and inhibits VEGF- and IL-1β-induced permeability; ω-linked acyl-VLC ceramides co-localize with tight junction complexes by ultrastructural analysis; intravitreal AAV2-hELOVL4 delivery reduces diabetes-induced retinal vascular permeability.\",\n      \"method\": \"ELOVL4 overexpression in endothelial cells, permeability assays, ultrastructure (EM) and lipidomics, intravitreal AAV delivery in diabetic mice, immunostaining of TJ proteins\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including in vivo AAV rescue and ultrastructural colocalization; establishes VLC ceramide-tight junction mechanistic link\",\n      \"pmids\": [\"29362226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ELOVL4 protein is expressed in spermatocytes during rat spermatogenesis; spermatocytes (with highest ELOVL4 protein levels) are the only testicular cells that produce C26-C32 VLC-PUFAs, directly correlating ELOVL4 enzymatic activity with VLC-PUFA synthesis in germ cells.\",\n      \"method\": \"Western blot, immunohistochemistry, [³H]arachidonate elongation assay in isolated spermatocytes, round spermatids, Sertoli cells; postnatal developmental expression analysis\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — enzymatic activity assay in primary cells correlated with protein levels; single lab\",\n      \"pmids\": [\"29724783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The SCA34-causing W246G mutant ELOVL4 protein is mislocalized (punctate and aggregated rather than ER-distributed) in patient-derived skin fibroblasts, supporting a dominant-negative effect on protein localization as a pathogenic mechanism.\",\n      \"method\": \"Immunohistochemistry of dermal fibroblasts from patient skin biopsy\",\n      \"journal\": \"Neurology. Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single imaging method in patient-derived cells; supports but does not independently establish dominant-negative mechanism\",\n      \"pmids\": [\"32211516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The SCA34-causing W246G ELOVL4 knock-in rat shows selectively impaired VLC-SFA synthesis but preserved VLC-PUFA synthesis in retina and skin; homozygous rats develop reduced ERG a- and b-wave amplitudes without photoreceptor neurodegeneration, revealing a role for VLC-SFA in regulating retinal function independent of neurodegeneration.\",\n      \"method\": \"Knock-in rat model, GC/MS lipid analysis, ERG, OCT, histology, immunolabeling\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — KI rat with lipidomics and multiple functional readouts; dissociates VLC-SFA from VLC-PUFA roles\",\n      \"pmids\": [\"32780351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"W246G mutant ELOVL4 rats show impaired motor function; cerebellar slice patch-clamp recordings reveal reduced LTP at parallel fiber-Purkinje cell synapses and reduced LTD at climbing fiber-Purkinje cell synapses, with no cerebellar neurodegeneration, establishing that SCA34 motor deficits arise from synaptic plasticity impairment.\",\n      \"method\": \"Knock-in rat model, cerebellar slice electrophysiology (LTP/LTD at PF-PC and CF-PC synapses), behavioral motor testing, neuroanatomical analysis\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — electrophysiological analysis of specific synaptic plasticity mechanisms; links ELOVL4 to cerebellar synaptic function\",\n      \"pmids\": [\"34227061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SCA34-causing ELOVL4 mutations L168F and W246G are deficient in VLC-SFA biosynthesis (especially W246G, which shows negligible VLC-SFA synthesis), while retaining VLC-PUFA biosynthetic capacity; L168F shows gain-of-function for certain VLC-PUFA species (38:5n3); selective VLC-SFA deficiency may underlie SCA34 and erythrokeratodermia pathology.\",\n      \"method\": \"Cell-based expression of WT, L168F, and W246G ELOVL4 variants with VLC-FA precursor supplementation, GC-MS lipid quantification\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic assay comparing multiple mutant variants to WT; identifies substrate-specific defects\",\n      \"pmids\": [\"36464075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SCA34-causing ELOVL4 mutations (Q180P, T233M, W246G, I171T, L168F) produce shorter ultra-long-chain PUFA-containing phosphatidylcholines (ULC-PCs) than WT, consistent with incomplete elongation; modeled amino acid substitutions are in transmembrane helices that interact with the ω-end of the substrate acyl-CoA; heterozygous Q180P and homozygous W246G knock-in mouse ES cells show reduced neuronal ULC-PC production.\",\n      \"method\": \"Cell-based ULC-PC elongation assay, structural modeling, knock-in mouse ES cell neuronal differentiation, lipidomics\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cell-based enzymatic assay with multiple SCA34 mutants, structural modeling, and KI ES cells; identifies molecular mechanism of SCA34 mutations\",\n      \"pmids\": [\"36748939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"W246G mutant ELOVL4 rat Purkinje cells show reduced mEPSC frequency (presynaptic defect), increased mIPSC frequency and amplitude, reduced paired-pulse ratio at PF-PC but increased at CF-PC synapses, exaggerated persistence of EPSC amplitude (larger readily releasable pool), and reduced dendritic spine density, identifying multiple specific presynaptic and postsynaptic mechanisms of synaptic dysfunction in SCA34.\",\n      \"method\": \"Patch-clamp recordings (mEPSC, mIPSC, PPR, high-frequency stimulation) from cerebellar Purkinje cells of SCA34-KI rats, dendritic spine morphometry\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — detailed electrophysiological dissection of synaptic mechanisms; multiple recording paradigms\",\n      \"pmids\": [\"37491316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ELOVL4 is a downstream target of the NOTCH-RIPK4-IRF6 signaling axis in skin; loss of Elovl4 alone is sufficient to trigger squamous cell carcinoma (SCC) development in autochthonous mouse models; overexpression of ELOVL4 suppresses tumor growth of Ripk4-deficient keratinocytes.\",\n      \"method\": \"Autochthonous mouse models (Pik3caH1047R oncogene with Ripk4/Irf6/Elovl4 conditional deletion), multiplexed in vivo CRISPR screening, transcriptional profiling, ELOVL4 overexpression rescue in Ripk4-deficient keratinocytes\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with functional rescue; multiple in vivo models establish pathway position\",\n      \"pmids\": [\"36765696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MYCN transcriptionally represses ELOVL4 in neuroblastoma cells; MYCN binds the ELOVL4 promoter in proximity to HDAC1, HDAC2, and Sp1 (shown by ChIP); ELOVL4 positively regulates neuronal differentiation and lipid droplet accumulation; MYCN silencing increases the ELOVL4 product FA34:6.\",\n      \"method\": \"ChIP (MYCN binding to ELOVL4 promoter), siRNA MYCN knockdown, in vitro differentiation with FA34:6 measurement, reporter assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP identifies MYCN as transcriptional repressor; single lab\",\n      \"pmids\": [\"34333551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Novel ELOVL4 L168S variant causes deficiency in both VLC-SFA and VLC-PUFA biosynthesis (unlike L168F which retains VLC-PUFA synthesis), as demonstrated by cell-based expression with precursor supplementation; associated with early childhood-onset rapidly progressive SCA34 with macular dysfunction.\",\n      \"method\": \"Cell-based expression of L168S ELOVL4 variant with VLC-PUFA and VLC-SFA precursor supplementation, GC-MS lipid quantification\",\n      \"journal\": \"Acta neuropathologica communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic cell-based assay; single case/lab\",\n      \"pmids\": [\"37568198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Contact cooling-induced ELOVL4 upregulation in wounded epidermis produces DHA and EPA that dampen TNFα and other pro-inflammatory cytokine expression, accelerating the transition from the inflammatory to the proliferative phase of wound healing; in vivo perturbation of ELOVL4 confirmed its functional requirement.\",\n      \"method\": \"Skin injury and skin organoid models, bulk/scRNA-seq, spatial transcriptomics, in vivo functional perturbation (ELOVL4 KD/OE), cytokine measurement\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KD/OE with molecular readouts; single lab with multiple methods\",\n      \"pmids\": [\"40083712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Testis-specific knockout of Elovl4 (Stra8-Cre) abolishes VLC-PUFA synthesis (>C26) in testes, causing abnormal spermatogenesis, reduced sperm count, sperm malformation, dramatic changes in Defbs gene family expression, decreased sperm motility, and severely reduced male fertility.\",\n      \"method\": \"Conditional KO mouse (Elovl4flox/flox, Stra8-Cre), GC/MS lipid analysis, spermatogenesis histology, sperm motility assay, fertility testing, RT-PCR and Western blot\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — conditional KO with biochemical and functional fertility readouts; establishes essential role of testicular ELOVL4/VLC-PUFA in male reproduction\",\n      \"pmids\": [\"41495266\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ELOVL4 is an ER-resident fatty acid condensing enzyme (elongase) whose activity depends on conserved active-site histidines and the ER microenvironment, and which is uniquely responsible for synthesizing very long-chain saturated fatty acids (VLC-SFA, ≥C28) and very long-chain polyunsaturated fatty acids (VLC-PUFA, C28-C38) in a tissue-specific manner; its products are incorporated into phosphatidylcholines and ceramides/sphingolipids in the retina, brain, skin, meibomian glands, and testis, where they regulate photoreceptor membrane integrity, synaptic vesicle release kinetics and cerebellar plasticity, epidermal permeability barrier (via omega-O-acylceramides), tight junction stability in retinal vessels, and male fertility; disease-causing C-terminal truncation mutants lose the dilysine ER-retention signal, mislocalize to aggresomes/outer-segment disks, lack elongase catalytic activity, and exert dominant-negative sequestration of wild-type ELOVL4, while distinct missense mutations (SCA34) selectively impair VLC-SFA over VLC-PUFA synthesis, causing incomplete elongation of ultra-long-chain acyl-CoAs and synaptic dysfunction without acute neurodegeneration.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ELOVL4 is an endoplasmic reticulum-resident fatty acid condensing enzyme (elongase) that uniquely catalyzes the synthesis of very long-chain saturated fatty acids (VLC-SFA, ≥C28) and very long-chain polyunsaturated fatty acids (VLC-PUFA, C28–C38) from C26 and shorter acyl-CoA precursors, with activity dependent on conserved active-site histidine residues and ER localization maintained by a C-terminal dilysine retrieval motif [PMID:18728184, PMID:24569140, PMID:15028284]. Its lipid products serve tissue-specific structural and signaling roles: omega-O-acylceramides are essential for the epidermal permeability barrier [PMID:17208947, PMID:21429867], VLC-PUFA-containing phosphatidylcholines support photoreceptor membrane integrity [PMID:22199362], VLC-ceramides stabilize retinal vascular tight junctions [PMID:29362226], VLC-SFAs regulate synaptic vesicle release kinetics and cerebellar synaptic plasticity [PMID:29168048, PMID:34227061], and testicular VLC-PUFAs are required for normal spermatogenesis and male fertility [PMID:41495266]. Dominant mutations causing autosomal dominant Stargardt-like macular dystrophy (STGD3) truncate the C-terminus, abolish elongase activity, and exert a dominant-negative effect by sequestering wild-type ELOVL4 into aggresomes, while distinct missense mutations causing spinocerebellar ataxia type 34 (SCA34) selectively impair VLC-SFA synthesis and produce incompletely elongated acyl chains, leading to synaptic dysfunction without acute neurodegeneration [PMID:23509295, PMID:16036915, PMID:36464075, PMID:36748939].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of ELOVL4 as the STGD3 disease gene established that a photoreceptor-expressed protein with homology to yeast fatty acid elongases underlies autosomal dominant Stargardt-like macular dystrophy via a 5-bp deletion causing C-terminal truncation.\",\n      \"evidence\": \"Genetic mapping, recombination breakpoint analysis, direct sequencing, and bioinformatic homology in STGD3 families\",\n      \"pmids\": [\"11138005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymatic activity was not directly demonstrated\", \"Mechanism of pathogenesis (loss-of-function vs. toxic gain-of-function) was unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Localization studies revealed that wild-type ELOVL4 resides in the ER via a C-terminal dilysine (KXKXX) retrieval motif, and that disease-causing truncations ablate this signal, causing mislocalization to aggregates or the Golgi, directly implicating ER residency in normal function.\",\n      \"evidence\": \"Immunofluorescence with organelle markers, immunoelectron microscopy in transfected COS-7, CHO, NIH-3T3, HEK293 cells and human photoreceptors\",\n      \"pmids\": [\"15028284\", \"15073583\", \"15557430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mislocalization per se or loss of enzymatic activity drives pathology was unresolved\", \"The ER microenvironment requirement for catalysis had not been tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The dominant-negative mechanism of STGD3 was established: truncated ELOVL4 physically interacts with and sequesters wild-type ELOVL4 into aggresome-like inclusions, forming higher-order oligomeric complexes and inducing the unfolded protein response.\",\n      \"evidence\": \"Co-immunoprecipitation, FRET, 2D gel electrophoresis, UPR marker analysis in COS-7 and HEK293T cells\",\n      \"pmids\": [\"16036915\", \"16163264\", \"16145543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether WT sequestration occurs in photoreceptors in vivo was uncertain\", \"Enzymatic activity of WT vs. mutant had not been measured directly\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Knockout and knock-in mouse models proved that ELOVL4 is the sole enzyme responsible for synthesizing ≥C28 fatty acids in skin, and that loss of these VLC-FAs (particularly omega-O-acylceramides) collapses the epidermal permeability barrier, causing neonatal lethality.\",\n      \"evidence\": \"Elovl4 knockout and Stgd3 knock-in mice with lipid profiling, electron microscopy, and transepidermal water loss assays\",\n      \"pmids\": [\"17208947\", \"17311087\", \"17304340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Brain and retinal phenotypes could not be assessed due to neonatal death\", \"VLC-PUFA vs. VLC-SFA contributions were not separated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Lipidomic analysis of STGD3 knock-in retinas revealed selective depletion of C32–C36 acyl phosphatidylcholines without ER stress markers, suggesting product deficiency rather than ER stress as the primary retinal pathogenic mechanism.\",\n      \"evidence\": \"Mass spectrometry lipid profiling and ER stress marker analysis of Stgd3 knock-in mouse retinas\",\n      \"pmids\": [\"17983602\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Heterozygous model may not fully recapitulate disease severity\", \"Protein toxicity vs. lipid loss was not definitively resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Direct enzymatic characterization proved that ELOVL4 is a fatty acid condensing enzyme that elongates C24:0 to C28–C30 saturated species and C20–C22 PUFAs to C28–C38 VLC-PUFAs, definitively establishing its biochemical function.\",\n      \"evidence\": \"Adenoviral Elovl4 expression in cardiomyocytes and ARPE-19 cells with fatty acid supplementation and GC-MS quantification\",\n      \"pmids\": [\"18728184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate specificity across different PUFA series was incompletely defined\", \"Whether activity required ER localization was untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Photoreceptor-specific conditional knockout demonstrated that ELOVL4 is essential for retinal VLC-PUFA-containing phosphatidylcholine synthesis and normal visual function, while epidermal transgenic rescue of neonatal lethality enabled study of tissue-specific roles.\",\n      \"evidence\": \"Cre-lox photoreceptor-specific KO with HPLC-MS lipidomics and ERG; involucrin-promoter transgenic rescue of Stgd3 homozygotes with lipid and barrier assays\",\n      \"pmids\": [\"22199362\", \"21429867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether VLC-PUFA loss alone is sufficient for photoreceptor degeneration was unclear\", \"Brain-specific functions remained unexplored\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Cell-free microsome assays confirmed that truncated ELOVL4 is catalytically dead and dominantly suppresses wild-type enzymatic activity; comparison of conditional KO mice (no degeneration despite VLC-PUFA loss) with STGD3 transgenic mice (degeneration) revealed that mutant protein toxicity, not mere VLC-PUFA deficiency, drives STGD3 retinal dystrophy.\",\n      \"evidence\": \"Cell-based and microsome condensation assays; rod- and cone-specific conditional KO vs. transgenic STGD3 mice with ERG, GC-MS, and electron microscopy\",\n      \"pmids\": [\"23509295\", \"23479632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific toxic mechanism of mislocalized mutant protein in photoreceptors was undefined\", \"Whether VLC-PUFA loss contributes to long-term retinal vulnerability remained open\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Active-site mutagenesis established that conserved histidine residues are required for ELOVL4 condensation activity and that ER displacement abolishes enzymatic function, proving the ER microenvironment is essential for catalysis; in Xenopus rods, the truncated mutant mislocalizes to outer segment disks.\",\n      \"evidence\": \"Overexpression of His-mutant and ER-retention-deficient ELOVL4 with GC-MS elongation assay; transgenic Xenopus photoreceptor imaging\",\n      \"pmids\": [\"24569140\", \"24833735\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure or detailed catalytic mechanism was available\", \"Whether outer-segment disk mislocalization is directly toxic was not shown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Using skin-rescued Elovl4 mutant mice, ELOVL4-derived VLC-SFAs were shown to regulate synaptic vesicle release kinetics in hippocampal neurons; exogenous VLC-SFA supplementation rescued the defective release rate, establishing a direct role for ELOVL4 lipid products in neurotransmission.\",\n      \"evidence\": \"Skin-rescued double transgenic mice, hippocampal slice electrophysiology, FM1-43 synaptic vesicle release assay, VLC-SFA rescue experiment\",\n      \"pmids\": [\"29168048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The molecular target of VLC-SFA at the synapse (membrane insertion, protein interaction) was unknown\", \"Whether VLC-PUFA also contributes to synaptic function was untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"ELOVL4-derived VLC ceramides were shown to stabilize tight junctions in retinal vascular endothelium, with ELOVL4 overexpression reducing VEGF- and IL-1β-induced permeability and AAV-mediated delivery preventing diabetic retinal vascular leakage in vivo.\",\n      \"evidence\": \"ELOVL4 overexpression in endothelial cells, permeability assays, EM colocalization with TJ, intravitreal AAV2-hELOVL4 in diabetic mice\",\n      \"pmids\": [\"29362226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The precise VLC-ceramide species responsible was not identified\", \"Whether this mechanism operates in non-retinal vascular beds was unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The SCA34-causing W246G knock-in rat revealed that ELOVL4 missense mutations selectively impair VLC-SFA synthesis while preserving VLC-PUFA production, dissociating the two product classes and demonstrating that VLC-SFA deficiency alone impairs retinal function without neurodegeneration.\",\n      \"evidence\": \"W246G knock-in rat with GC/MS lipidomics, ERG, OCT, and histology\",\n      \"pmids\": [\"32780351\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single residue change creates substrate selectivity was structurally unresolved\", \"Long-term neurodegeneration over the full lifespan was not fully assessed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Cerebellar electrophysiology in W246G rats established that SCA34 motor deficits arise from impaired synaptic plasticity—reduced LTP at parallel fiber–Purkinje cell synapses and reduced LTD at climbing fiber–Purkinje cell synapses—rather than from neurodegeneration.\",\n      \"evidence\": \"Cerebellar slice patch-clamp recordings of LTP and LTD, behavioral motor testing, neuroanatomical analysis in SCA34 knock-in rats\",\n      \"pmids\": [\"34227061\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether VLC-SFA supplementation rescues cerebellar plasticity deficits was not tested\", \"The biophysical mechanism by which VLC-SFA modulates plasticity was undefined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Systematic comparison of SCA34 mutants (L168F, W246G) confirmed that each selectively impairs VLC-SFA biosynthesis while preserving (or even enhancing) VLC-PUFA synthesis, establishing substrate-specific catalytic defects as the molecular basis of SCA34.\",\n      \"evidence\": \"Cell-based expression of WT, L168F, and W246G ELOVL4 with VLC-FA precursor supplementation and GC-MS quantification\",\n      \"pmids\": [\"36464075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural explanation for substrate-specific impairment was available\", \"Whether VLC-SFA replacement therapy could treat SCA34 was untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Multiple SCA34 mutations were mapped to transmembrane helices contacting the ω-end of the substrate acyl-CoA, and all produced incompletely elongated ultra-long-chain PUFA-containing phosphatidylcholines, providing the first structural-mechanistic explanation for SCA34 pathogenesis; detailed electrophysiology further identified pre- and postsynaptic defects including reduced mEPSC frequency, altered paired-pulse ratios, and reduced dendritic spine density in Purkinje cells.\",\n      \"evidence\": \"Cell-based ULC-PC elongation assay with five SCA34 mutants, structural modeling, knock-in ES cell neuronal differentiation lipidomics; patch-clamp recordings of mEPSC/mIPSC, PPR, and spine morphometry in SCA34-KI rat Purkinje cells\",\n      \"pmids\": [\"36748939\", \"37491316\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental 3D structure of ELOVL4 exists\", \"Whether incomplete elongation products have toxic gain-of-function effects is unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"ELOVL4 was positioned downstream of the NOTCH–RIPK4–IRF6 signaling axis in skin, and conditional Elovl4 deletion alone was sufficient to promote squamous cell carcinoma, revealing a tumor-suppressive function.\",\n      \"evidence\": \"Autochthonous mouse models with conditional deletion, multiplexed in vivo CRISPR screening, ELOVL4 overexpression rescue in Ripk4-deficient keratinocytes\",\n      \"pmids\": [\"36765696\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The tumor-suppressive mechanism (lipid product-mediated or cell-autonomous signaling) is uncharacterized\", \"Relevance to human SCC is not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Testis-specific Elovl4 knockout abolished VLC-PUFA synthesis in testes, causing abnormal spermatogenesis, sperm malformation, decreased motility, and severely reduced male fertility, establishing ELOVL4 as essential for male reproduction.\",\n      \"evidence\": \"Conditional KO mouse (Elovl4flox/flox; Stra8-Cre) with GC/MS lipid analysis, histology, sperm motility and fertility assays\",\n      \"pmids\": [\"41495266\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific sperm membrane lipid species responsible for motility defects are uncharacterized\", \"Whether VLC-PUFA supplementation can rescue fertility is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the three-dimensional structure of ELOVL4 explaining substrate selectivity and SCA34 mutation effects, the molecular mechanism by which VLC-SFAs modulate synaptic vesicle fusion machinery and cerebellar plasticity, and whether lipid replacement therapies can rescue neurological or retinal disease phenotypes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental structure of ELOVL4 or any ELOVL family member exists\", \"The biophysical mechanism linking VLC-SFA/PUFA to synaptic vesicle release and plasticity is unknown\", \"Therapeutic potential of VLC-FA supplementation or gene therapy for SCA34 and STGD3 is unexplored in clinical settings\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [11, 14, 16, 18, 29, 30]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [11, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 2, 3, 6, 18, 19, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [7, 8, 11, 14, 15, 29, 30, 36]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ELOVL1\",\n      \"ELOVL2\",\n      \"ELOVL5\",\n      \"ELOVL6\",\n      \"ELOVL7\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}